Overall Technical outlook

Price Summary

Aurobindo Pharma Limited's stock started trading at 1140.1 on 2025-07-15, climbed to 1157.0, fell to 1134.0, and closed 1.04% up at 1152.0, with 847057 shares traded.
Over the previous 52 weeks, the stock reached a high of 1569.4 and a low of 1051.75.
The future price of AUROPHARMA is anticipated to range from 1100.0 to 1930.0, with an expected mean price of 1393.2307, according to the recommendations of 26 analysts.

Technicals

Support and Resistance: The price of 1152.0 is supported at 1114.5 and encounters resistance at 1156.15. This suggests key levels where the price might find stability, with 1114.5 providing a base and 1156.15 acting as an upper boundary for AUROPHARMA.
AUROPHARMA supportResistance f675b7
Support/Resistance for AUROPHARMA


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
AUROPHARMA aroon f675b7
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
AUROPHARMA bbands f675b7
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a strong resistance level that could impede any upward trends. This resistance indicates that the market may struggle to break higher, reflecting ongoing bearish sentiment for AUROPHARMA.
AUROPHARMA psar f675b7
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral stance, with no definitive indication of an upward or downward trend for AUROPHARMA. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
AUROPHARMA stoch f675b7
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
AUROPHARMA trippleSMA f675b7
Tripple SMA chart for Aurobindo Pharma Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.